The Procter Gamble Company

The Gillette Company

Kenneth Edward Yelm

Gregory Mark Bunke

John Christian Haught

Rajan Keshav Panandiker

Bernard William Kluesener

Alan David Willey

Nikolai Nikolaevich Issaev

Robb Richard Gardner

Robert Edward Shumate

Jacob Robert Adams

Michael Sliger

Eric Navok

Kady Lynn Willison

Michael Dean Sliger

Photoactivators comprise a photoactive moiety and a hydrophilic moiety. The photoactivators preferably comprise less than about 35%, by weight of the photoactivator, of the photoactive moiety. The photoactivators can be activated to a photo-excited state by excitation with incident radiation of a wavelength between about 350 nm and 750 nm, preferably between about 350 nm and about 420 nm. The photoactivators further encompass those having certain chemical formulations.

Photoactivators

The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect. Preparation schemes for neoisomers of other menthyl derivatives which are useful as coolants, including esters, ethers, carboxy esters and other N-substituted carboxamides are also provided.

Synthesis of cyclohexane derivatives useful as sensates in consumer products

The present application relates to molecules comprising one or more beta-hydroxyamine moieties, for example, aminosilicones and compositions such as consumer products comprising such molecules, as well as processes for making and using such molecules and such compositions. The aforementioned process is safer, more efficient and thus more economical. Thus, the aforementioned moleculers may be more widely used.

Process of making &#x3b2;-hydroxyamino compounds

A primary cell having an anode comprising lithium and a cathode comprising iron disulfide (FeS) and carbon particles. The electrolyte comprises a lithium salt dissolved in a solvent mixture which contains 1,3-dioxolane and isosorbide dimethyl ether. The solvent mixture may comprise 1,3-dioxolane, 1,2-dimethoxyethane and additive isosorbide dimethyl ether. The isosorbide dimethyl ether comprises typically between about 2 and 15 percent by weight of the solvent mixture and improves cell service life and performance. A cathode slurry is prepared comprising iron disulfide powder, carbon, binder, and a liquid solvent. The mixture is coated onto a conductive substrate and solvent evaporated leaving a dry cathode coating on the substrate. The anode and cathode can be spirally wound with separator therebetween and inserted into the cell casing with electrolyte then added.

Lithium cell with iron disulfide cathode and improved electrolyte

The invention provides hydroxamic acid-containing compounds which are useful as inhibitors of matrix metalloproteases and which are effective in treating conditions associated with excess activity of these enzymes. In particular, the present invention relates to a compound having a structure according to Formula I ##STR1## wherein (A)R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently selected from various substituents; and

Hydroxamic acid-containing inhibitors of matrix metalloproteases

Growing community of inventors

Hamilton, OH, United States of America

Kenneth Edward Yelm